Cassava Sciences corrects diluted EPS for H1 2024 to ($0.28) from ($1.72)

FILANA THERAPEUTICS, INC.

Corrected diluted EPS for six months ended June 30, 2024 is $(0.28), not $(1.72) as originally reported.
No other financial figures in the August 8, 2024 earnings release are affected by this amendment.
Corrected figure matches diluted EPS reported in the Form 10-Q filed on August 8, 2024.
Amendment filed on August 9, 2024; initial 8-K remains unchanged except for the EPS correction.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.